openPR Logo
Press release

Achondroplasia (Musculoskeletal) Market Competitive Research And Global Outlook 2021 To 2026

11-08-2021 12:30 PM CET | Health & Medicine

Press release from: Market Insights Reports

The Achondroplasia (Musculoskeletal) Market report offers an in-depth assessment of market dynamics, the competitive landscape, segments, and regions in order to help readers to become familiar with the Achondroplasia (Musculoskeletal) market. It particularly sheds light on market fluctuations, pricing structure, uncertainties, potential risks, and growth prospects to help players to plan effective strategies for gaining successful in the Achondroplasia (Musculoskeletal) market. Importantly, it allows players to gain deep insights into the business development and market growth of leading companies operating in the Achondroplasia (Musculoskeletal) market.

Get a Free Sample Copy of This Report:

https://www.marketinsightsreports.com/reports/11023648749/achondroplasia-musculoskeletal-drugs-in-development-2021/inquiry?Mode=namita

Top Leading Companies of Achondroplasia (Musculoskeletal) Market are - Ascendis Pharma AS, Astellas Pharma Inc, BioMarin Pharmaceutical Inc, BridgeBio Pharma Inc, Pfizer Inc, PhaseBio Pharmaceuticals Inc, Ribomic Inc, Sanofi, TagCyx Biotechnologies and others.

Industry News and Updates:

BioMarin Expands Vosoritide Clinical Program

SAN RAFAEL, Calif., Nov. 9, 2020-- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced today that the Company is expanding its clinical program for vosoritide, an investigational analog of C-type Natriuretic Peptide (CNP), with two new Phase 2 studies.  The first study is sponsored by BioMarin to investigate the safety of vosoritide in infants with achondroplasia at risk of life-threatening foramen magnum compression.  The second study is an investigator-initiated study sponsored by Children's National Hospital in Washington, D.C. to investigate vosoritide in children with selected genetic forms of short stature, which together represent addressable patient populations of approximately 275,000.

Market Overview:

Achondroplasia is a bone growth disorder that causes disproportionate dwarfism. This is caused by mutations in the FGFR3 gene. Symptoms include decreased muscle tone, apnea, hydrocephalus, short arms and legs, disproportionately large head compared to the body and kyphosis. Treatment includes growth hormones.

Investigator Observers Strong Growth in Specific Regions:

– Europe Market (Germany, UK, France, Russia, Italy)

– Center East and Africa Market (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)

– South America Market (Brazil, Argentina, Colombia)

– North America Market (United States, Canada, Mexico)

– Asia Pacific Market (China, Japan, Korea, India, Southeast Asia).

Scope of Achondroplasia (Musculoskeletal) Market Report:

- The report provides a snapshot of the global therapeutic landscape of Achondroplasia (Musculoskeletal).
- The report reviews product therapeutics for Achondroplasia (Musculoskeletal) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The report covers the products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The report features descriptive drug profiles for the products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The report reviews key companies involved in Achondroplasia (Musculoskeletal) maket therapeutics and enlists all their major and minor projects.
- The report evaluates Achondroplasia (Musculoskeletal) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The report encapsulates all the dormant and discontinued pipeline projects.
- The report reviews latest news related to the product therapeutics for Achondroplasia (Musculoskeletal)

Browse Full Report at:

https://www.marketinsightsreports.com/reports/11023648749/achondroplasia-musculoskeletal-drugs-in-development-2021?Mode=namita

Reasons to Buy This Report:

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Achondroplasia (Musculoskeletal).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for market projects by understanding Achondroplasia (Musculoskeletal) depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from market.

We Offer Customization on Report Based on Specific Client Requirement:

- Country Level analysis for any 5 countries of your choice.

- Competitive analysis of any 5 key market players.

- 40 analyst hours to cover any other data point.

Contact Us:
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

About Us:

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Achondroplasia (Musculoskeletal) Market Competitive Research And Global Outlook 2021 To 2026 here

News-ID: 2454129 • Views:

More Releases from Market Insights Reports

Cold Chain Monitoring Market May See a Big Move | BlueAir, Denso, Eureka Forbes, Honeywell
Cold Chain Monitoring Market May See a Big Move | BlueAir, Denso, Eureka Forbes, …
Market Insights Reports published a new research publication on "Cold Chain Monitoring Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Cold Chain Monitoring market was mainly driven by the increasing R&D spending across the world. Some of the key players
Outbound Logistics Market Next Big Thing | Major Giants- Draexlmaier, Faurecia, Grupo Antolin
Outbound Logistics Market Next Big Thing | Major Giants- Draexlmaier, Faurecia, …
Market Insights Reports published a new research publication on "Outbound Logistics Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Outbound Logistics market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled in
Veterinary Telemedicine Market May See a Big Move | Nestle, Deuerer, The J.M. Smucker
Veterinary Telemedicine Market May See a Big Move | Nestle, Deuerer, The J.M. Sm …
Market Insights Reports published a new research publication on "Veterinary Telemedicine Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Veterinary Telemedicine market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled in
Precision Planting Market is Set to Fly High in Years to Come
Precision Planting Market is Set to Fly High in Years to Come
Market Insights Reports published a new research publication on "Precision Planting Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Precision Planting market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled in

All 5 Releases


More Releases for Achondroplasia

Achondroplasia Market Industry Trends and Forecast to 2029
This Achondroplasia Market report has been prepared by considering several fragments of the present and upcoming market scenario. The market insights gained through this market research analysis report facilitates more clear understanding of the market landscape, issues that may interrupt in the future, and ways to position definite brand excellently. It consists of most-detailed market segmentation, thorough analysis of major market players, trends in consumer and supply chain
Achondroplasia Treatment Market An Professional Research Report 2023-2029 | Surv …
Achondroplasia is a disorder of bone growth that prevents the changing of cartilage (particularly in the long bones of the arms and legs) to bone. It is characterized by dwarfism, limited range of motion at the elbows, large head size (macrocephaly), small fingers, and normal intelligence. Achondroplasia (ACH) is a rare disease that causes short stature (adult height of approximately 130 cm for males and approximately 125 cm for females)
Achondroplasia Treatment Market Size, Share, Industry, Forecast to 2030
The Achondroplasia Treatment Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Achondroplasia Treatment market. This report explores all the key factors affecting the growth of the global Achondroplasia Treatment market, including
Achondroplasia Treatment Market to witness Great Growth in Forecast to 2030
The professional report on The Achondroplasia Treatment Market research provides valuable insights on business size, ongoing trends, drivers, potential risks, outcomes, and significant segments. Additionally, the Industry Report presents precise assumptions to forecast future market growth. Drawing from industry experts, the report's findings offer actionable measures that help readers develop effective strategies for the Achondroplasia Treatment market's future growth. Furthermore, the research provides a comprehensive view of present market needs
Achondroplasia Market: Pipeline Review, H2 2022
HTF Market Intelligence released a new research report of 60 pages on title 'Achondroplasia - Pipeline Review, H2 2022' with detailed analysis, forecast and strategies. The market Study is segmented by key a region that is accelerating the marketization. The study is a perfect mix of qualitative and quantitative Market data collected and validated majorly through primary data and secondary sources. This section also provides the scope of different
Achondroplasia Market Insight, Epidemiology and Market Forecast - 2027
Achondroplasia Market research report is the new statistical data source added by Infinity Business Insights. Achondroplasia is a genetic disease characterised by dwarfism as its major symptom. The limbs and legs of people who have the disease are short, but the torso is usually average length. Males have an average adult height of 131 centimetres (4 ft 4 in) while girls have an average adult height of 123 centimetres (4